CN1204511A - 一种抗癌药物及其生产工艺 - Google Patents
一种抗癌药物及其生产工艺 Download PDFInfo
- Publication number
- CN1204511A CN1204511A CN 97108988 CN97108988A CN1204511A CN 1204511 A CN1204511 A CN 1204511A CN 97108988 CN97108988 CN 97108988 CN 97108988 A CN97108988 A CN 97108988A CN 1204511 A CN1204511 A CN 1204511A
- Authority
- CN
- China
- Prior art keywords
- medicine
- cancer therapy
- therapy drug
- dmso
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
实施例编号 | 聚乙二醇PEG-400 | 1,2-丙二醇 | 辛二酸 | 对甲苯磺酸 | 二甲基亚砜 | 乙醇 | 磺胺 |
4 | 10% | 5% | 1% | 1% | 3% | 0 | 对甲苯磺胺酰80% |
5 | 60% | 27% | 1% | 1% | 0 | 1% | 对甲苯磺酰胺10% |
6 | 15% | 10% | 20% | 20% | 20% | 5% | 邻甲苯磺酰胺10% |
7 | 20% | 15% | 10% | 5% | 5% | 5% | N-乙基对甲苯磺酰胺40% |
8 | 25% | 30% | 5% | 5% | 2% | 3% | N-乙基邻甲苯磺酰胺30% |
9 | 30% | 10% | 10% | 10% | 10% | 20% | N-环己基对甲苯磺酰胺10% |
10 | 20% | 20% | 5% | 15% | 20% | 0 | N-环己基邻甲苯磺酰胺20% |
11 | 药物改为对甲苯磺酰胺、邻甲苯磺酰胺、N-乙基对甲苯磺酰胺、N-乙基邻甲苯磺酰胺、N-环己基对甲苯磺酰胺、N-环己基邻甲苯磺酰胺各取等分。其余同实施例1。 | ||||||
12 | 药物改为N-环己基邻甲苯磺酰胺、N-环己基对甲苯磺酰胺,重量比2∶1,其余同实施例2。 | ||||||
13 | 药物改为N-乙基邻甲苯磺酰胺、N-环己基对甲苯磺酰胺,重量比2∶1,其余同实施例4。 |
批次 组别 | 剂量(/kg/d×10d) | 动物数 | 体重 | 平均瘤重(X±SD)(g) | 抑瘤率(%) | P值* | |||
开始 | 最后 | 开始 | 最后 | ||||||
1 | NS(对照)溶剂(对照)CTX实施例1实施例1实施例1 | 2.0ml2.0ml18.0mg0.5ml1.0ml2.0ml | 111111101011 | 111111999 | 21.521.919.922.121.922.2 | 27.826 027.928.127.824.1 | 3.05±0.932.56±0.701.81±0.221.76±0.341.48±0.331.24±0.53 | -16.140.731.342.251.6 | >0.05*<0.01*<0 01**<0 01**<0.01** |
2 | NS(对照)溶剂(对照)CTX实施例1实施例1实施例1 | 2.0ml2.0ml18.0mg0.5ml1.0ml2.0ml | 111011111011 | 111011111011 | 20.320.220.320.420.120.0 | 32.629.527.826.828.727.8 | 2.92±0.853.12±0.771.57±0.632.15±0.782.00±0.861.56±0.61 | --6.846.231.335.950.0 | >0.05*<0.01*<0.01**<0.01**<0.01** |
3 | NS(对照)溶剂(对照)CTX实施例1实施例1实施例1 | 2.0ml2.0ml18.0mg0.5ml1.0ml2.0ml | 111111111214 | 101110101214 | 20.920.620.920.820.120.6 | 28.528.328.527.525 624 5 | 2.35±0.612.48±0.640.94±0.411.62±0.341.39±0.311.03±0.29 | --5.560.034.743.958.6 | >0.05*<0.01*<n01**<0.01**<0.01** |
批次 | 组别 | 剂量(/kg/d×10d ) | 动物数 | 体重 | 平均瘤重(X±SD)(g) | 抑瘤率(%) | P值* | ||
开始 | 最后 | 开始 | 最后 | ||||||
4 | NS(对照)溶剂(对照)CTX实施例1实施例1实施例1 | 2.0ml2.0ml18.0mg0.5ml1.0ml2.0ml | 111111111111 | 11111110109 | 22.522.422.422.022.422.4 | 30.327.130.929.127.527.3 | 2.83±0.973.36±0.691 37±0.471 64±0.681.76±0.441.04±0.62 | --7.151.645.941.965.7 | >0.05*<0.01*<0.01**<0.01**<0.01** |
5 | NS(对照)溶剂(对照)CTX实施例1实施例1实施例1 | 2.0ml2.0ml18.0mg0.5ml1.0ml2.0ml | 111010121212 | 111010111110 | 22.222.322.622.422.622.7 | 31.027.929.127.427.627.7 | 2.76±0.733.05±0.901.29±0 431.79±0.451.69±0.421.10±0.30 | -10.553.541.344.663.9 | >0.05*<0.01*<0.01**<0.01**<0.01** |
6 | NS(对照)溶剂(对照)CTX实施例1实施例1实施例1 | 2.0ml2.0ml18.0mg0.5ml1.0ml2.0ml | 111211111213 | 11111091111 | 19.119.419.319.019.119.5 | 27.826.226.425.324.524.3 | 2.40±0.732 33±0 401.14±0.281.63±0.391.37±0.301.14±0 28 | -2.952.530.041.250.9 | >0.05*<0.01*<0.01**<0.01**<0.01** |
病种 | 例数 | CR | PR | NP |
乳腺癌软组织肉瘤皮肤鳞癌肺癌术后肠壁转移鼻咽癌放疗后颈部转移颈部恶性淋巴瘤 | 232111 | 2111 | 12 | 11 |
剂量(g/kg) | 动物数(只) | 体重(g) | 肿瘤重量(g)X±SD | 抑瘤率☆(%) | ||
开始 | 结束 | 开始 | 结束 | |||
0.920.40.45环磷酰胺空白5%吐温 | 202020201020 | 101516181019 | 40.2039.1040.7539.8532.3040.85 | 41.4041.7142.8342.5043.0048.24 | 5.30±2.20**6.20±3.19**6.57±2.57**1.75±1.16**8.85±2.919.31±2.60 | 433633--- |
剂量(g/kg) | 动物数(只) | 体重(g) | 肿瘤重量(g)X±SD | 抑瘤率☆(%) | ||
开始 | 结束 | 开始 | 结束 | |||
0.920.640.45环磷酰胺空白5%吐温 | 202020201020 | 111719181019 | 35.0131.2532.5539.8532.3040.85 | 39.4540.4438.3542.5043.0048.24 | 3.86±2.92*#5.03±3.97*#8.35±2.69*#1.75±1.16**8.85±2.919.31±2.60 | 61491582-- |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97108988A CN1073415C (zh) | 1997-07-03 | 1997-07-03 | 磺酰胺类化合物在制备抗癌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN97108988A CN1073415C (zh) | 1997-07-03 | 1997-07-03 | 磺酰胺类化合物在制备抗癌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1204511A true CN1204511A (zh) | 1999-01-13 |
CN1073415C CN1073415C (zh) | 2001-10-24 |
Family
ID=5170816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN97108988A Expired - Lifetime CN1073415C (zh) | 1997-07-03 | 1997-07-03 | 磺酰胺类化合物在制备抗癌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1073415C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6727287B2 (en) | 2001-04-16 | 2004-04-27 | Pts International, Inc. | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
CN1957021B (zh) * | 2004-01-29 | 2011-06-29 | 成均馆大学校产学协力团 | pH值和温度敏感性水凝胶 |
CN102389410A (zh) * | 2011-11-03 | 2012-03-28 | 黄漫翔 | 对-甲苯磺酰胺在制备癌症治疗药物中的应用 |
KR20170095926A (ko) * | 2015-01-06 | 2017-08-23 | 티엔진 홍리 지엔 다 캉 메디컬 테크놀로지 컴퍼니 리미티드 | 설폰아마이드류 약학 조성물 |
CN109475517A (zh) * | 2016-06-10 | 2019-03-15 | 吴崇汉 | 用于治疗恶性胸腔积液的新颖苯磺酰胺组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340148A (en) * | 1961-03-22 | 1967-09-05 | Gillette Inhibitor Co | Treatment of fungus diseases of the skin |
-
1997
- 1997-07-03 CN CN97108988A patent/CN1073415C/zh not_active Expired - Lifetime
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6727287B2 (en) | 2001-04-16 | 2004-04-27 | Pts International, Inc. | Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
CN1957021B (zh) * | 2004-01-29 | 2011-06-29 | 成均馆大学校产学协力团 | pH值和温度敏感性水凝胶 |
CN102389410A (zh) * | 2011-11-03 | 2012-03-28 | 黄漫翔 | 对-甲苯磺酰胺在制备癌症治疗药物中的应用 |
KR20170095926A (ko) * | 2015-01-06 | 2017-08-23 | 티엔진 홍리 지엔 다 캉 메디컬 테크놀로지 컴퍼니 리미티드 | 설폰아마이드류 약학 조성물 |
JP2018501291A (ja) * | 2015-01-06 | 2018-01-18 | 天津紅日健▲達▼康医▲薬▼科技有限公司Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd | スルホンアミド系医薬組成物 |
KR101949810B1 (ko) | 2015-01-06 | 2019-02-19 | 티엔진 홍리 지엔 다 캉 메디컬 테크놀로지 컴퍼니 리미티드 | 설폰아마이드류 약학 조성물 |
US11040020B2 (en) * | 2015-01-06 | 2021-06-22 | Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd | Sulfonamide pharmaceutical composition |
CN109475517A (zh) * | 2016-06-10 | 2019-03-15 | 吴崇汉 | 用于治疗恶性胸腔积液的新颖苯磺酰胺组合物 |
CN109475517B (zh) * | 2016-06-10 | 2021-06-29 | 共信医药科技股份有限公司 | 用于治疗恶性胸腔积液的新颖苯磺酰胺组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN1073415C (zh) | 2001-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1140272C (zh) | 抗肿瘤剂 | |
CN1222294C (zh) | 含吗啉蒽环类衍生物和抗癌剂的联合制剂 | |
CN1263466C (zh) | 活性炭输液剂、其制备方法及其在制备治疗癌症药中的应用 | |
CN1224383C (zh) | 一类新型降低血糖化合物 | |
JPH01503146A (ja) | 身体組織の治療方法および身体組織への医薬の投与方法 | |
CN1204511A (zh) | 一种抗癌药物及其生产工艺 | |
CN1169561C (zh) | 一种治疗肛肠病、消化道溃疡和乳腺病的药物及制法 | |
CN100350931C (zh) | 一种用于治疗牙痛的中药搽剂及其制备方法 | |
CN1468602A (zh) | 柚皮苷在制备支持性治疗非典型性肺炎药物中的应用 | |
CN1210023C (zh) | 卡铂前体脂质体注射剂及其制造方法 | |
CN1176655C (zh) | 利福喷丁或利福平脂质体灌注液、注射液及制备方法 | |
CN1194696C (zh) | 一种注射用药物组合物、含有该药物组合物的制剂及其制备方法 | |
CN1265805C (zh) | 降血糖中药口服制剂及其制备方法 | |
CN1504191A (zh) | 葫芦素脂质体组方及其制剂 | |
CN1063632C (zh) | 一种治疗皮肤病的外用搽剂 | |
CN1561988A (zh) | 一种紫杉醇微球抗癌药物的制备方法 | |
CN1244398A (zh) | 中、西药结合治疗皮肤真菌病症的改进型酊剂 | |
CN1283272C (zh) | 一种抗癌药物及其制备方法 | |
CN1109545C (zh) | 螯合铁的制剂及其制备方法 | |
CN1706462A (zh) | 消痤片及其制备方法 | |
CN1292266A (zh) | 硝酸铵在制药、食品和保健品中的应用 | |
CN1511834A (zh) | 苯并异硒唑衍生物的免疫调节和生物治疗作用 | |
RU2076710C1 (ru) | Лекарственное средство для лечения опухолевых заболеваний | |
CN105832771B (zh) | 一种治疗消化道念珠菌病的药物及其制备方法 | |
CN1313099C (zh) | 炭气凝胶输液剂、其制备方法及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: GUO SHAOWEN WU CHONGHAN WU CHONGWEN Effective date: 20120530 Owner name: BEIJING JIANDAKANG NEW MEDICINE DEVELOPMENT CO., L Free format text: FORMER OWNER: WU YIZHUANG Effective date: 20120530 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510000 GUANGZHOU, GUANGDONG PROVINCE TO: 100020 CHAOYANG, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120530 Address after: 100020, room 1406, pan Li building, 22 Wai Wai Street, Beijing, Chaoyang District Patentee after: Beijing Jian Kang drug development Co. Ltd. Address before: Guangzhou City, Guangdong province 510000 City Changhua Street No. 12 2 floor Co-patentee before: Guo Shaowen Patentee before: Wu Yizhuang Co-patentee before: Wu Chonghan Co-patentee before: Wu Chongwen |
|
ASS | Succession or assignment of patent right |
Owner name: TIANJIN HONGRI JIANDAKANG PHARMACEUTICAL TECHNOLOG Free format text: FORMER OWNER: BEIJING JIANDAKANG NEW MEDICINE DEVELOPMENT CO., LTD. Effective date: 20120828 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100020 CHAOYANG, BEIJING TO: 300457 HANGU, TIANJIN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120828 Address after: 300457 TEDA SME Park, 276 Huang Hai Road, Tianjin Development Zone, 4-C-203 Patentee after: TIANJIN HONGRI JIANDAKANG PHARMACEUTICAL CO., LTD. Address before: 100020, room 1406, pan Li building, 22 Wai Wai Street, Beijing, Chaoyang District Patentee before: Beijing Jian Kang drug development Co. Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20011024 |
|
CX01 | Expiry of patent term |